Form 4: Sera Prognostics Officer Boniface Executes Stock Options and Sells Shares Under 10b5-1 Plan

John J. Boniface, Chief Scientific Officer of Sera Prognostics, exercised stock options and sold shares of Class A Common Stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On March 27 and 28, 2024, John J. Boniface, the Chief Scientific Officer of Sera Prognostics, exercised stock options to acquire shares of Class A Common Stock.
• He then sold portions of these shares on the same days.
• The transactions were executed under a Rule 10b5-1 trading plan adopted on December 15, 2023.
• On March 27, 2024, 48,909 shares were acquired via option exercise at $0.91 per share and then sold at a weighted average price of $9.62.
• On March 28, 2024, 24,474 shares were acquired via option exercise at $0.91 per share and then sold at a weighted average price of $9.04.
• Following these transactions, Boniface still beneficially owns 139,771 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by an officer. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about insider trading activity under a pre-arranged plan.

Industry Context

Form 4 filings are a routine part of the regulatory landscape for publicly traded companies, providing transparency into the trading activities of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the sale of shares by a company officer.
• The impact is likely limited as the sales were conducted under a pre-arranged trading plan.

Key Dates